Farallon Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
Other funds holding AGIO
Farallon Capital Management's AGIO Position: Q3 2026 in Review
Farallon Capital Management increased its Agios Pharmaceuticals (AGIO) stake by 0.37% in Q3 2026, buying an estimated $770K and bringing the position to 5,939,400 shares worth $197M. The position accounts for 0.85% of the portfolio, ranked #30.
Farallon Capital Management first reported a position in AGIO in Q4 2019 and has held it in 28 quarters since. The position peaked at $252M in Q3 2024. 243 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.
- Farallon Capital Management held 5,939,400 shares of Agios Pharmaceuticals worth $197M as of Q3 2026.
- Farallon Capital Management bought 22,000 Agios Pharmaceuticals shares in Q3 2026, an estimated $770K.
- Agios Pharmaceuticals made up 0.85% of Farallon Capital Management's portfolio in Q3 2026, its #30 holding.
- Farallon Capital Management first reported a position in Agios Pharmaceuticals in Q4 2019 and has held it in 28 quarters since.
- Farallon Capital Management's Agios Pharmaceuticals position peaked at $252M in Q3 2024.
- 243 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.
Based on Farallon Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.